Rolston, Kenneth V.
American Society of Clinical Oncology · Seattle Cancer Care Alliance · Emory University · UC San Diego Health System · CancerCare Manitoba · Winship Cancer Institute · University of Cincinnati
5 papers on CoChat
Most cited papers
- Verified
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases
Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility
Cited by 3,463
- Verified
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases
Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility
Cited by 1,964
- Verified
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline
Flowers, C. R., Seidenfeld, J., Bow, E. J., Karten, C., Gleason, C., Hawley, D. K., Kuderer, N. M., Langston, A. A., Marr, K. A., Rolston, K. V. I., et al. (2013) · Journal of Clinical Oncology
Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility
Cited by 448
- Verified
Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K., et al. (2018) · Journal of Clinical Oncology
Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility
Cited by 426
- Verified
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007): Stable incidence but changing epidemiology of a still frequently lethal infection
Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer
Antifungal resistance and susceptibilityNeutropenia and Cancer Infections
Cited by 269
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free